Bicara Therapeutics Inc (NAS:BCAX)
$ 29.34 +2.47 (+9.19%) Market Cap: 1.93 Bil Enterprise Value: 1.39 Bil PE Ratio: 0 PB Ratio: 3.74 GF Score: 12/100

Bicara Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 2, 2026 / 06:10 PM GMT
Release Date Price: $17.59 (+4.83%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BCAX.OQ - Bicara Therapeutics Inc
Bicara Therapeutics Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 06:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right, good afternoon, everyone. Tyler Van Buren here, senior biotech analyst at TD Cowan.

Thank you very much for joining TD Cowan's 46th annual healthcare conference. For our next session, we have a hybrid presentation and fireside chat style Q&A with Bikara, and it's my pleasure to introduce Ryan Coheap, the President and COO. Ryan, privileged to have you here.

Thank you very much for joining us. Feel free to get started on the presentation.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Great.

Thank you, Tyler, and thank
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot